A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
Titel:
A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
Auteur:
Castro-Malaspina, H. Papadopoulos, E. Ann, J. Miguel Angel, P. James, Y. Katherine, H. Farid, B. Vinot, P. Trudy, S. Nancy, K. Marcel, V. Hanna, D. Richard, O.